Predictors of survival in hepatocellular carcinoma patients

Annals of Transplantation

Volumn 20, Issue , 2015, Pages 596-603

  Gokcan, Hale ^a   Savaş, Nurten ^b   Oztuna, Derya ^c   Moray, Gokhan ^b   Boyvat, Fatih ^b   Haberal, Mehmet ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Carcinoma; Combined modality therapy; Hepatocellular; Survival analysis

Indexed keywords

ALBUMIN; ALCOHOL;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; TUMOR VOLUME; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FACTUAL DATABASE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER NEOPLASMS; LIVER RESECTION; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TURKEY;

AGED; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CAUSE OF DEATH; CHEMOEMBOLIZATION, THERAPEUTIC; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TURKEY;

EID: 84943591795     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.894878     Document Type: Article

References (48)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94: 153-6.
2. Osaki Y, Nishikawa H. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review. Hepatol Res, 2014; 45: 59-74
3. Marrero JA, Fontana RJ, Fu S et al: Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol, 2005; 42: 218-24
4. Graf D, Vallböhmer D, Knoefel WT et al: Multimodal treatment of hepatocellular carcinoma. Eur J Intern Med, 2014; 25: 430-37
5. Zieniewicz K, Patkowski W, Nyckowski P et al: Results of liver transplantation for hepatocellular cancer. Ann Transplant, 2007; 12(1): 11-14
6. Mazzaferro V, Regalia E, Doci R et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl Med, 1996; 334: 693-99
7. Karakayali H, Moray G, Sozen H et al: Expanded criteria for liver transplantation in patients with hepatocellular carcinoma. Transplant Proc, 2006; 38: 575-78
8. Cabrera R, Nelson DR: Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther, 2010; 31: 461-76
9. Bruix J, Sherman M, Llovet JM et al: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol, 2001; 35: 421-30
10. Sala M, Forner A, Varela M, Bruix J: Prognostic prediction in patients with hepatocellular carcinoma. Semin Liver Dis, 2005; 25: 171-80
11. Taura N, Ichikawa T, Miyaaki H et al: Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma. Med Sci Monit, 2013; 19: 742-50
12. Chan SC: Liver transplantation for hepatocellular carcinoma. Liver Cancer, 2013; 2: 338-44
13. Kudo M, Izumi N, Kokudo N et al: Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis, 2011;29: 339-64
14. European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol, 2012; 56: 908-43
15. Mazzaferro V, Llovet JM, Miceli R et al: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol, 2009; 10: 35-43
16. Kwon CH, Kim DJ, Han YS et al: HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis, 2007; 25: 313-19
17. Kaido, Ogawa K, Mori A et al: Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma. Surgery, 2013; 154: 1053-60
18. Duffy JP, Vardanian A, Benjamin E et al: Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg, 2007; 246: 502-9, discussion 509-11
19. Yao FY, Ferrell L, Bass NM et al: Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl, 2002; 8: 765-74
20. Graziadei IW, Sandmueller H, Waldenberger P et al: Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl, 2003; 9: 557-63
21. Yao FY, Kerlan RK Jr, Hirose R et al: Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intentionto- treat analysis. Hepatology, 2008; 48: 819-27
22. Majno P, Giostra E, Mentha G: Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials? Liver Transpl, 2007; 13: S27-35
23. Clavien PA, Lesurtel M, Bossuyt PM et al.; OLT for HCC Consensus Group: Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol, 2012; 13: e11-22
24. Mazzaferro V, Battiston C, Perrone S et al: Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg, 2004; 240: 900-9
25. Makuuchi M, Donadon M, Torzilli G: Hepatic resection for hepatocellular carcinoma in cirrhosis. Ann Ital Chir, 2008; 79: 111-15
26. Fan ST, Mau Lo C, Poon RT et al: Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg, 2011; 253: 745-48
27. Schwartz ME, Shrager B: Surgical resection for hepatocellular carcinoma in the noncirrhotic: the Western experience. Recent Results Cancer Res, 2013; 190: 85-100
28. Roayaie S, Obeidat K, Sposito C et al: Resection of hepatocellular cancer £2 cm: results from two Western centers. Hepatology, 2013; 57: 1426-35
29. Shrager B, Jibara G, Schwartz M, Roayaie S: Resection of hepatocellular carcinoma without cirrhosis. Ann Surg, 2012; 255: 1135-43
30. Taura K, Ikai I, Hatano E et al: Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg, 2006; 244: 265-73
31. Ikai I, Arii S, Kojiro M et al: Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer, 2004; 101: 796-802
32. Llovet JM, Schwartz M, Mazzaferro V: Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis, 2005; 25: 181-200
33. Ohishi H, Uchida H, Yoshimura H et al: Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology, 1985; 154: 25-29
34. Lencioni R: Loco-regional treatment of hepatocellular carcinoma. Hepatology, 2010; 52: 762-73
35. Nicolini A, Martinetti L, Crespi S et al: Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. J Vasc Interv Radiol, 2010; 21: 327-32
36. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma. Hepatology, 2005; 42: 1208-36
37. Llovet JM, Real MI, Montaña X et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet, 2002; 359: 1734-39
38. Lo CM, Ngan H, Tso WK et al: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology, 2002; 35: 1164-71
39. Takayasu K, Arii S, Ikai I et al: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology, 2006; 131: 461-69
40. Burrel M, Reig M, Forner A et al: Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads. Implications for clinical practice and trial design. J Hepatol, 2012; 56: 1330-35
41. Livraghi T, Meloni F, Di Stasi M et al: Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology, 2008; 47: 82-89
42. Shiina S, Teratani T, Obi S et al: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology, 2005; 129: 122-30
43. Nishikawa H, Osaki Y, Iguchi E et al: Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes. J Gastroenterol, 2013; 48(8): 951-65
44. Feng K, Yan J, Li X et al: A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol, 2012; 57: 794-802
45. Chen MS, Li JQ, Zheng Y et al: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg, 2006; 243: 321-28
46. Huang J, Yan L, Cheng Z et al: A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg, 2010; 252: 794-802
47. Zhou Y, Zhao Y, Li B et al: Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol, 2010; 10: 78
48. Hasegawa K, Kokudo N, Makuuchi M et al: Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol, 2013; 58: 724-29